Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ACHC
BUYAcadia Healthcare Company, Inc. · Healthcare · United States · $3.2B · Avg Vol: $108M/d
COMPANY DESCRIPTION
Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services, operating an extensive network of inpatient psychiatric facilities, residential treatment centers, and specialty treatment facilities across the United States. The company holds a strong market position due to its broad geographic diversification, specialized treatment programs, and commitment to clinical excellence. Its scale and expertise create a significant competitive moat in addressing growing mental health needs.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.6B | 2.9B | 3.2B | 3.3B | 8.3% | 3.4B | 3.4B | 3.6B | 4.5% |
| EPS | 3.05 | -0.24 | 2.79 | -12.16 | -4.4% | -12.18 | — | — | — |
| Shares | 89.9M | 91.3M | 91.8M | 90.5M | +0.6% | 92.0M | — | — | — |
| Debt | 1.5B | 1.5B | 2.1B | 2.6B | 20.0% | 2.7B | — | — | — |
| Equity | 2.8B | 2.8B | 3.1B | 1.9B | -11.5% | — | — | — | — |
| Op CF | 380.6M | 462.3M | 129.7M | 131.9M | -29.8% | 182.0M | — | — | — |
| Inv CF | -305.8M | -397.2M | -736.5M | -556.2M | — | — | — | — | — |
| Fin CF | -110.9M | -62.7M | 583.0M | 481.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ACHC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc.(you) | $3.2B | 73 | BUY |
| LFST | LifeStance Health Group, Inc. | $4.2B | 77 | BUY |
| SGRY | Surgery Partners, Inc. | $2.1B | 68 | BUY |
| OPCH | Option Care Health, Inc. | $3.4B | 61 | HOLD |
| CON | Concentra Group Holdings Parent, Inc. | $4.0B | 83 | STRONG BUY |
| INNV | InnovAge Holding Corp. | $1.6B | 77 | BUY |
| NHC | National HealthCare Corporation | $3.5B | 90 | STRONG BUY |
| ASTH | Astrana Health, Inc. | $2.0B | 85 | STRONG BUY |
| PNTG | The Pennant Group, Inc. | $1.4B | 66 | BUY |
| PACS | PACS Group, Inc. | $7.4B | 78 | BUY |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%